For instance, Loi et al. used gene expression profiles from primary breast tumors containing PIK3CA mutations to design a signature of PI3K activation to predict PI3K-Akt-mTOR pathway activity in an independent dataset [12]. The gene discussed is AKT1; the disease is breast neoplasm.